Back to top
more

ELUTIA INC (ELUT)

(Delayed Data from NSDQ)

$4.03 USD

4.03
35,908

+0.02 (0.50%)

Updated Aug 23, 2024 04:00 PM ET

After-Market: $3.99 -0.04 (-0.99%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ELUT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Elutia Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 19 17 30 40 3
Receivables 6 21 6 7 7
Notes Receivable 0 0 0 0 0
Inventories 4 10 10 10 7
Other Current Assets 2 3 1 3 1
Total Current Assets 31 51 47 60 18
Net Property & Equipment 0 1 1 1 1
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 12 15 18 22 25
Deposits & Other Assets 0 0 0 0 0
Total Assets 43 69 67 83 45
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 5 7 4
Accounts Payable 2 2 2 2 2
Current Portion Long-Term Debt 3 0 8 6 2
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 9 10 6 6 4
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 28 30 5 6 6
Total Current Liabilities 43 43 26 27 18
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 1 1
Convertible Debt 0 0 0 0 0
Long-Term Debt 20 24 10 18 20
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 19 6 17 17 17
Minority Interest (Liabilities) 0 0 0 0 44
Total Liabilities 82 74 54 62 100
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 137 133 119 101 2
Retained Earnings -176 -138 -105 -80 -57
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -39 -5 14 21 -55
Total Liabilities & Shareholder's Equity 43 69 67 83 45
Total Common Equity -39 -5 14 21 -55
Shares Outstanding 23.20 16.14 13.50 10.20 NA
Book Value Per Share -1.66 -0.31 1.00 2.04 0.00

Fiscal Year End for Elutia Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 18 13 19 15 9
Receivables 8 6 6 10 15
Notes Receivable 0 0 0 0 0
Inventories 3 3 4 7 9
Other Current Assets 1 2 2 8 2
Total Current Assets 30 24 31 39 36
Net Property & Equipment 0 0 0 0 1
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 3 0
Deferred Charges 0 0 0 0 0
Intangibles 10 11 12 13 13
Deposits & Other Assets 0 0 0 0 0
Total Assets 42 35 43 55 52
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 3 4 2 3 3
Current Portion Long-Term Debt 3 2 3 0 10
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 7 9 9 11 12
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 25 22 28 31 17
Total Current Liabilities 40 38 43 45 43
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 19 20 20 25 25
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 48 19 14 6
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 106 86 82 84 74
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 157 143 137 137 134
Retained Earnings -222 -194 -176 -166 -157
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -64 -50 -39 -29 -22
Total Liabilities & Shareholder's Equity 42 35 43 55 52
Total Common Equity -64 -50 -39 -29 -22
Shares Outstanding 24.27 24.27 23.20 23.10 16.20
Book Value Per Share -2.65 -2.07 -1.66 -1.28 -1.37